Thursday, July 29, 2010
GSK will settle Paxil birth defect lawsuit
According to Bloomberg Businessweek, it is believed that GlaxoSmithKline, the manufacturer for the antidepressant medication Paxil, will agree to pay $1 billion to resolve more than 800 cases alleging the drug caused birth defects in some of the user's children.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment